These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3922084)

  • 1. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
    Perret BA; Furlan M; Beck EA
    Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
    Johnson AJ; Macdonald VE; Brind J
    Vox Sang; 1979; 36(2):72-6. PubMed ID: 313629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
    Burnouf-Radosevich M; Burnouf T
    Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matrices.
    Saundry RH; Savidge GF
    Bioseparation; 1991; 2(3):177-86. PubMed ID: 1368084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
    Amrani DL; Mosesson MW; Hoyer LW
    Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration.
    Kaersgaard P; Barington KA
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):357-67. PubMed ID: 9792522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates.
    López-Fernández MF; López-Berges C; Corral M; García-Talavera JR; López Borrasca A; Batlle J
    Vox Sang; 1987; 52(1-2):15-9. PubMed ID: 3111088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the von Willebrand factor/factor VIII complex produced by a novel purification process.
    Ahn JW; Chang ES; Jung YJ; Kim SR; Seong BL; Ha SH
    Arch Pharm Res; 2020 Jul; 43(7):714-723. PubMed ID: 32666302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a coagulation accelerating factor (CAF) in glomerulonephritis.
    Salem HH; Howard MA; Koutts J; Firkin BG
    Br J Haematol; 1985 Mar; 59(3):485-96. PubMed ID: 3918561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave-thawed plasma for cryoprecipitate production.
    Bass H; Trenchard PM; Mustow MJ
    Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoaffinity purification of factor VIII complex.
    Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
    Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispersity of human factor VIII--Von Willebrand factor.
    van Mourik JA; Bolhuis PA
    Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.